SAM
AGN

Stansberry Asset Management’s Allergan plc AGN Stock Holding History

Stansberry Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-111,576
Closed -$19.8M – 42
2020
Q1 		$19.8M Buy
111,576
+9,181
+9% +$1.73M 10.39% 3
2019
Q4 		$19.6M Buy
+102,395
New +$18.5M 7.97% 2
2018
Q4 		– Sell
-2,255
Closed -$430K – 104
2018
Q3 		$430K Buy
+2,255
New +$414K 0.12% 64

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Stansberry Asset Management's AGN Position: Q2 2020 in Review

Stansberry Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 111,576 shares — an estimated $19.8M sold.

Stansberry Asset Management first reported a position in AGN in Q3 2018 and held it in 3 quarters. The position peaked at $19.8M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Stansberry Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Stansberry Asset Management sold 111,576 Allergan plc shares in Q2 2020, an estimated $19.8M.
  • Stansberry Asset Management first reported a position in Allergan plc in Q3 2018 and held it in 3 quarters.
  • Stansberry Asset Management's Allergan plc position peaked at $19.8M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Stansberry Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.